|
|
Customized hyperopia treatment shows promise
- Article from:
-
Ophthalmology Times
- Article date:
-
June 15, 2008
- Author:
-
|
Copyright informationCopyright Advanstar Communications, Inc. Jun 15, 2008. Provided by ProQuest LLC. (Hide copyright information)
|
1-year outcomes
Wavefront excimer laser system demonstrates excellent predictability, visual acuity results
Reviewed by Stephen G. Slade, MD
Chicago-The 1-year results of the FDA safety and efficacy trial of customized hyperopia treatment with a wavefront excimer laser system (Technolas 217z Zyoptix, Bausch & Lomb) showed that the predictability of the treatment was excellent, with 69% of patients within 0.5 D of the intended correction. Stephen G. Slade, MD, reported the results at the American Society of Cataract and Refractive Surgery annual meeting.
Investigators conducted this 2-year study at four clinical sites. The ablations were determined using Hartmann-Shack aberrometry and ...